← Eichor
Study identifier: NCT07546188 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

Condition: Lymphoma, Non-Hodgkin · Care Coordination  ·  Sponsor: Grand Hôpital de Charleroi

PhaseN/A
Planned participants210
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Marie Detrait, MD, PhD  ·  0032 60 11 20 08  ·  marie.detrait@ghdc.be

Aline Gillain, MedSciences  ·  0032 60 11 00 89  ·  aline.gillain@ghdc.be

Always discuss trial participation with your own doctor first.

Locations (1)

Grand Hôpital de CharleroiCharleroi, Hainaut, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07546188